en Umicore Licenses Cross-Coupling Catalysts from MIT The business unit Precious Metals Chemistry of Umicore is expanding its existing cross-coupling catalyst portfolio with Buchwald precatalysts that the Belgian materials technology group licensed from the Massachusetts Institute of Technology (MIT). Fri, 17 Aug 2018 09:07:00 +0000 Cabot to Take KMG Chemicals for $1.6 Billion Cabot Microelectronics has agreed to buy KMG Chemicals for around $1.6 billion, boosting its position in the semiconductor industry. The deal adds KMB’s high-purity chemicals to Cabot’s polishing slurries and pads that are used to make computer chips, virtually doubling Cabot’s revenue to roughly $1 billion and generating a combined EBITDA of around $320 million. Fri, 17 Aug 2018 05:35:00 +0000 Emergent Buys PaxVax for $270 Million US specialty biopharma Emergent BioSolutions has agreed to buy PaxVax in an all-cash deal worth $270 million. PaxVax is majority owned by an affiliate of American private equity firm Cerberus Capital Management. Fri, 17 Aug 2018 04:00:00 +0000 Bayer-Monsanto Knot now Firmly Tied After completing the transfer of certain agrochemicals assets to BASF on Aug. 16, Bayer has begun integrating Monsanto into its organization. Anti-trust regulations had required operating the two companies separately since all regulatory hurdles were cleared, and the German group became sole owner of its former US rival in June Fri, 17 Aug 2018 03:07:00 +0000 Astellas Boosts Eye Disease Platform with Quethera Japan’s Astellas Pharma has acquired Cambridge, UK-based Quethera, a gene therapy company focused on developing novel treatments for eye disease, such as glaucoma. Thu, 16 Aug 2018 07:30:00 +0000 ICI Pakistan and Huntsman in Textiles Pact ICI Pakistan has signed a deal to manufacture, formulate and distribute Huntsman Textile Effects’ products in Pakistan. The Karachi-headquartered group said the agreement combines its market knowledge and strong customer and supplier relationships with Huntsman’s innovative dyes and textile auxiliaries. Thu, 16 Aug 2018 05:05:00 +0000 Australia grants Merck KGaA CRISPR Patent The Australian Patent Office has granted an application by Germany’s Merck KGaA to patent the use of paired CRISPR nickases. The Darmstadt-based group said, these “represent a significant step in increasing safety by driving specificity through a highly flexible and efficient approach to reduce off-target effects.” The method is said to improve CRISPR’s ability to fix diseased genes while not affecting healthy ones. Thu, 16 Aug 2018 02:54:00 +0000 SABIC Partners with Design Firm on New Applications Saudi petrochemicals and plastics group SABIC is working with US product design firm Nottingham Spirk to develop new uses for its specialty materials. With this partnership SABIC wants to leverage its ability to expand value for its customers while also contributing to Saudi Vision 2030. Wed, 15 Aug 2018 09:57:00 +0000 BASF Coatings Invests in China Complex Chemetall, the surface treatment business of BASF’s Coatings division, is investing in a new site in Zhejiang province, China. The complex, which will be located in the Dushan Port Economic Development Zone of Pinghu, will house production, warehousing, a laboratory and administrative offices. Completion is planned by 2021. Wed, 15 Aug 2018 07:00:00 +0000 Drugmakers Eyed in Iraqi Bribe Claims Major international drugmakers and at least one medical device supplier are acknowledging one by one that they are under scrutiny from the US Department of Justice for allegedly funding Iraqi terrorists during the Iraq war and beyond. Wed, 15 Aug 2018 05:00:00 +0000 Carlyle ready to list Atotech? US private equity investor Carlyle is preparing an initial public offering for Berlin-based  specialty chemicals group Atotech, reports the news agency Reuters. The Washington, DC-headquartered private equity group has asked investment banks to participate in the flotation, which could take place in New York next year, or possibly Germany, Reuters sources said. Wed, 15 Aug 2018 02:58:00 +0000 Panel Discussion on Flow Chemistry During the Achema Congress 2018, CHEManager hosted a panel discussion on Monday, June 11, 2018 at the Congress Center in Frankfurt. Tue, 14 Aug 2018 13:16:00 +0000 Achema 2018: Challenges and Opportunities of Micro Reaction Technologies During the Achema Congress 2018, CHEManager hosted a panel discussion on Monday, June 11, 2018 at the Congress Center in Frankfurt. Tue, 14 Aug 2018 13:08:00 +0000 Perrigo to Separate Prescription Pharmaceuticals Perrigo has announced that its board of directors has approved a plan to separate its prescription pharmaceuticals (Rx) business, following a strategic portfolio review. Generic drugmakers such as the Netherlands-domiciled company have suffered in recent years as falling prices have hit their bottom lines. Tue, 14 Aug 2018 07:30:00 +0000 Saudi Aramco, Air Products in Gasification JV Saudi Aramco continues to move swiftly toward building up a major presence in the downstream sector. Tue, 14 Aug 2018 05:00:00 +0000 Ineos Chief Takes Flak for Monaco Move Ineos Chairman Jim Ratcliffe appears to be growing increasingly unpopular in his native land. The 46-year-old businessman is now being sharply criticized for his announcement that he will move his legal residence to tax haven Monaco. Tue, 14 Aug 2018 03:22:00 +0000 PTT Global Chemical Buys PTA/PET Stakes Thailand’s PTT Global Chemical (PTTGC) agreed on Aug. 8 to acquire stakes of 74% in both PTA producer Siam Mitsui PTA and PET producer Thai PET Resin from SCG Chemicals and Mitsui Chemicals, respectively. PTTGC will pay a total of about $125 million for the holdings. Under the terms of the agreement, PTTGC and its subsidiary TOC Glycol will acquire shares in Siam Mitsui PTA, and TOC Glycol will buy shares in Thai PET Resin. Mon, 13 Aug 2018 07:30:00 +0000 Ligand Makes $43 Million Bid for Vernalis US biopharma Ligand Pharmaceuticals has announced its intention to buy UK biotech Vernalis for approximately $43 million. Mon, 13 Aug 2018 05:00:00 +0000 Bayer/Monsanto Lose Glyphosate Case Bayer and Monsanto have lost their first legal case as a merged company. A jury in the US state of California ordered the former US agribusiness market leader, since June part of the German agrochemicals and pharmaceutical group, to pay $289 million in damages to a 46-year-old school groundskeeper who was diagnosed in 2014 with non-Hodgkin’s lymphoma. Mon, 13 Aug 2018 02:46:00 +0000 AstraZeneca Settles Whistleblower Lawsuits AstraZeneca has agreed to pay $110 million to settle a pair of whistleblower lawsuits in the US that accused it of fraudulently marketing Seroquel and Crestor to Texas Medicaid providers. The case, filed in 2013 by the Texas Attorney General, initially sought $5 billion. Fri, 10 Aug 2018 07:30:00 +0000 Invista to build ADN Plant in China Reacting to what it said is strong local demand for the intermediate used to produce PA 6.6, US nylon giant Invista has begun engineering work on a world-scale adiponitrile (ADN) plant in China. Fri, 10 Aug 2018 05:00:00 +0000 PET giant Indorama buys French Recycler PET market leader Indorama Ventures is acquiring French recycler Sorepla for an undisclosed sum. The company with 58 employees is one of the largest recyclers in Europe, operating three production lines, for rPET, rHDPE and food-grade pellets, with a combined capacity of 52,000 t/y. Fri, 10 Aug 2018 03:33:00 +0000 Former Long-time M+W Executive Gerald Schneider Joins CRB Group Gerald Schneider, a long-time business leader at M+W Group, has joined US competitor CRB Group as managing director for European commercial operations. Thu, 09 Aug 2018 19:03:00 +0000 Taiwan’s CPC Mulls Cracker in India Indian Oil has announced that Taiwan energy giant CPC is considering investing $6.6 billion in a petrochemicals complex at its refinery in Paradip, Odisha, India. A delegation from Taiwan, which comprised government officials and senior executives from CPC, met with Indian ministers on Jul. 31 to discuss the proposal. Thu, 09 Aug 2018 07:26:00 +0000 Regeneron and Bluebird Bio in Cancer Therapy Pact US biotech companies Regeneron and bluebird bio are collaborating and applying their respective technology platforms to discover, develop and commercialize novel immune cell therapies for cancer. Thu, 09 Aug 2018 05:00:00 +0000